首页> 外文期刊>Chemico-biological interactions >Genetic alterations in the Catnb gene but not the H-ras gene in hepatocellular neoplasms and hepatoblastomas of B6C3F(1) mice following exposure to diethanolamine for 2 years.
【24h】

Genetic alterations in the Catnb gene but not the H-ras gene in hepatocellular neoplasms and hepatoblastomas of B6C3F(1) mice following exposure to diethanolamine for 2 years.

机译:暴露于二乙醇胺2年后,B6C3F(1)小鼠的肝细胞肿瘤和肝母细胞瘤中Catnb基因的遗传变化,但没有H-ras基因的遗传变化。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The present study characterized the immunohistochemical localization of beta-catenin protein in hepatocellular neoplasms and hepatoblastomas in B6C3F(1) mice exposed to diethanolamine (DEA) for 2 years and evaluated genetic alterations in the Catnb and H-ras genes which are known to play important roles in the pathogenesis of liver malignancies. Genomic DNA was isolated from paraffin sections of each liver tumor. Catnb exon 2 (corresponds to exon 3 in human) genetic alterations were identified in 18/18 (100%) hepatoblastomas from DEA exposed mice. Deletion mutations (15/18, 83%) were identified more frequently than point mutations (6/18, 33%) in hepatoblastomas. Eleven of 34 (32%) hepatocellular adenomas and carcinomas from DEA treated mice had mutations in exon 2 of the beta-catenin gene, while only 1 of 10 spontaneous neoplasms had a deletion mutation of codon 5-6. Common to all liver neoplasms (hepatocellular adenomas, carcinomas and hepatoblastomas) was membrane staining for the beta-catenin protein, while cytoplasmic and nuclear staining was observed only in hepatoblastomas. The lack of H-ras mutations in hepatocellular neoplasms and hepatoblastomas suggests that the ras signal transduction pathway is not involved in the development of liver tumors following DEA exposure which is different from that of spontaneous liver tumors that often contain H-ras mutations.
机译:本研究的特点是暴露于二乙醇胺(DEA)2年的B6C3F(1)小鼠的肝细胞瘤和肝母细胞瘤中β-catenin蛋白的免疫组织化学定位,并评估了已知发挥重要作用的Catnb和H-ras基因的遗传改变在肝恶性肿瘤发病中的作用。从每个肝肿瘤的石蜡切片中分离基因组DNA。在暴露于DEA的小鼠的18/18(100%)肝母细胞瘤中鉴定出Catnb外显子2(对应于人类中的外显子3)遗传改变。在肝母细胞瘤中,发现突变(15 / 18,83%)比点突变(6 / 18,33%)更常见。来自DEA处理的小鼠的34个肝细胞腺瘤和癌中的11个(32%)在β-catenin基因的外显子2上有突变,而10个自发肿瘤中只有1个具有5-6密码子的缺失突变。 β-catenin蛋白的膜染色是所有肝肿瘤(肝细胞腺瘤,癌和肝母细胞瘤)的共同特征,而仅在肝母细胞瘤中才观察到细胞质和核染色。肝细胞肿瘤和肝母细胞瘤中缺乏H-ras突变表明,DEA暴露后ras信号转导途径不参与肝肿瘤的发生发展,这不同于通常包含H-ras突变的自发性肝肿瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号